AURA Competitors & Alternatives

Compare Aura Biosciences Inc with similar stocks in the same industry

Biotechnology

AURA

Main Stock
$7.21
+1.41%
Tradestie Score
31
Market Cap
$382.04M
Analyst Upside
+130.2%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Ocular Oncology Therapeutics
Competitive Moat: None
Core Technology Stack: Virus-like drug conjugates, AU-011 photodynamic therapy
Major Customers 2
Future oncology clinics Academic medical centers
Critical Suppliers 2
CROs for clinical trials Biomanufacturing partners
Direct Ecosystem Rivals 1

Top Competitors

215 stocks in Biotechnology
Company Price Market Cap P/E Score Action
VIR Vir Biotechnology, Inc. Common Stock
$9.76
-2.01%
$791.82M - 35 Compare
OLMA Olema Pharmaceuticals, Inc. Common Stock
$7.15
-5.42%
$757.72M - 33 Compare
AVBP ArriVent BioPharma, Inc. Common Stock
$11.86
-8.84%
$748.90M - 45 Compare
TBPH Theravance Biopharma, Inc.
$17.03
$726.21M 16.4 51 Compare
NRIX Nurix Therapeutics, Inc. Common stock
$15.01
-3.04%
$718.62M 6.4 52 Compare
TYRA Tyra Biosciences, Inc. Common Stock
$19.77
-1.27%
$715.25M - 31 Compare
DAWN Day One Biopharmaceuticals, Inc. Common Stock
$21.53
+0.19%
$704.73M - 51 Compare
PVLA Palvella Therapeutics, Inc. Common Stock
$145.03
-4.89%
$699.30M - 49 Compare
TERN Terns Pharmaceuticals, Inc. Common Stock
$52.95
+0.04%
$683.46M - 49 Compare
ANL ANL
$9.97
-6.03%
$677.47M - 48 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2836)

215 stocks in this industry